Vaccines for Latent Viral Infections

Author(s): Kallie Appleton, Ghaith Al Eyd and Liljana Stevceva

DOI: 10.2174/9781681081328115010008

Varicella-Zoster Virus Infections and Vaccine Advances

Pp: 61-70 (10)

Buy Chapters

* (Excluding Mailing and Handling)

  • * (Excluding Mailing and Handling)

Abstract

SHS investigation development is considered from the geographical and historical viewpoint. 3 stages are described. Within Stage 1 the work was carried out in the Department of the Institute of Chemical Physics in Chernogolovka where the scientific discovery had been made. At Stage 2 the interest to SHS arose in different cities and towns of the former USSR. Within Stage 3 SHS entered the international scene. Now SHS processes and products are being studied in more than 50 countries.

Abstract

Varicella Zoster Virus (VZV) causes a highly contagious infection, chicken pox and has the capacity to cause latent persistent infection of the dorsal root ganglia. The latent virus can reemerge inducing painful blistering of the skin called herpes zoster or shingles. Worldwide varicella immunization with an attenuated OKA/Merck VZV considerably reduced the incidence of the disease but did not prevent latency. Introduction of a second dose of the vaccine and the vaccine for people over 50, Zostavax, consisting of a much larger dose of the same vaccine virus, reduced the incidence of chicken pox but did not prevent latency and reemergence of the virus as herpes zoster. This review provides an overview of the structure of the virus, mechanism of infection and known evasion mechanisms that VZV uses to establish latency and persistence.

Recommended Chapters

We recommend

Favorable 70-S: Investigation Branching Arrow

Authors:Bentham Science Books